top of page
Meet the team 
​

The ReIMAGINE studies have been run across multiple London sites and have been a successful collaboration of our various academic institutions and NHS trusts

Patient and Public Engagement 
Steve
Tuck
​

A prostate cancer survivor -  Steve's role is to work with fellow men diagnosed with prostate cancer and relatives to ensure that the patient is at the centre of the study.  

Yellow Twitter.png
Steve Tuck_grey.jpg
Patient representative
Saran
Green
​

Saran is out dedicated Patient and Public Involvement Co-ordinator and liaises directly with our patient reps

KCL.png
PPI  coordinator
Our patient involvement projects
​

Events, Webinars, BAME patient group, newsletter....

Find Out More.png
Read why we think Patient involvement is so important
Clinical trials unit
Chris
brew-graves
​

NCITA programme manager and interim CTU manager Chris helps support and deliver the ReIMAGINE studies  

NCITA logo.png
project manager
Rosie
Clow
​

Rosie is a qualified nurse with a background in emergency medicine and post-surgical recovery, and is responsible for the day-to-day management of the ReIMAGINE studies

Yellow linked in.png
headshot 2.jpg
clinical trial manager
Dr
Tom Syer
​

Tom is a clinician and imaging research fellow for the ReIMAGINE Risk study, with responsibilities for the MRI processing, image analysis and co-ordination of the ReIMAGINE AI-challenge

TS headshot.jpg
Dr
Teresa Marsden
​

Teresa is Clinical Fellow for the ReIMAGINE studies and the RECONCILE study 

UCL.png
imaging fellow
clinical fellow
Jo Hadley
​

Since its launch Jo has been a CTP for ReIMAGINE across all sites, and now also contributes to the management of RECONCILE 

UCL.png
Ashling
Henderson
​

After previously working as a clinical scientist, Ashling has contributed first as a tissue technician and now as a CTP for ReIMAGINE, alongside the RECONCILE study

Ashling headshot_edited.jpg
senior clinical trial Practitioner
clinical trial Practitioner
NCITA logo.png

This study is being launched with funding of £4.1m from the Medical Research Council and £1m from Cancer Research UK, as part of the MRC's Stratified Medicine Initiative. 

MRCLogo_RGB_Steve.png
MRC_a.jpg

© 2018 ReIMAGINE

bottom of page